Daily FNArena News

Marcus Reubenstein of APAC News argues Australia is remiss in focusing on the economy while ignoring the actual virus.

The Chartist highlights the value of risk management at times of turmoil with the S&P500 technically set to bounce, or maybe not.

While several risks remain, Fonterra has emerged from the first stage of its restructure with a positive earnings outlook for FY20.

While the impact of the pandemic on Ramsay Health Care’s hospital income is uncertain most brokers agree, for the longer term, the hospitals are quality assets, catering to the demands of an ageing population.

Coca-Cola Amatil has positives and negatives from the impact of the coronavirus outbreak but remains well-placed to deal with the crisis.

Altium may have slightly lowered FY20 guidance but brokers are confident there is a long-term opportunity in the stock, and the valuation is attractive.

As a substantial exporter of iron ore to China’s recovering steel industry, does the share price of BHP Group deserve to be slammed so hard?

Cochlear has withdrawn FY20 guidance and expects the subsequent recovery in implant surgery will be slow.

While promising nothing, Michael Gable of Fairmont Equities would not be surprised if an S&P500 relief rally begins from this point.

Peter Switzer of the Switzer Report debates the obvious question.